126109000: Levonorgestrel (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\...

\Sex hormone (substance)\Progesterone receptor agonist\Synthetic progestogen (substance)\Levonorgestrel

\Steroid hormone\Levonorgestrel

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid\...

\Norsteroid\Levonorgestrel

\Estrane\Levonorgestrel

\Steroid hormone\Levonorgestrel

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Levonorgestrel	Is a	Norgestrel	false	Inferred relationship	Some
Levonorgestrel	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Progestational hormone	false	Inferred relationship	Some
Levonorgestrel	Is a	Synthetic progestogen (substance)	true	Inferred relationship	Some
Levonorgestrel	Is a	Norsteroid	true	Inferred relationship	Some
Levonorgestrel	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Gonadal hormone	false	Inferred relationship	Some
Levonorgestrel	Is a	Steroid hormone	true	Inferred relationship	Some
Levonorgestrel	Is a	Gonadal hormone	false	Inferred relationship	Some
Levonorgestrel	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Progesterone receptor agonist (disposition)	true	Inferred relationship	Some
Levonorgestrel	Is a	Estrane	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Levonorgestrel adverse reaction	Causative agent (attribute)	True	Levonorgestrel	Inferred relationship	Some	1
Product containing levonorgestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Allergy to levonorgestrel	Causative agent (attribute)	False	Levonorgestrel	Inferred relationship	Some
Levonorgestrel [combined oral contraceptive]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Levonorgestrel [progestogen contraceptive]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing precisely levonorgestrel 30 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Levonorgestrel 52mg intrauterine system	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Levonorgestrel 37.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing levonorgestrel 0.75 mg/1 each oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Ethinyl estradiol + levonorgestrel 0.03mg/0.15mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing only ethinyl estradiol 0.05 mg and levonorgestrel 0.25 mg/1 each oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Ethinyl estradiol + levonorgestrel 0.15mg/0.03mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Climara pro	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Levonorgestrel + estradiol transdermal system	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Climara pro levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing ethinylestradiol and levonorgestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	2
Levonorgestrel 1.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Lutera 28 tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Levonorgestrel 75 mg prolonged-release subcutaneous implant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing estradiol and levonorgestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Levonorgestrel-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing levonorgestrel in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Allergy to levonorgestrel	Causative agent (attribute)	True	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel-releasing intrauterine system	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Levonorgestrel-releasing implant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some
Product containing precisely levonorgestrel 30 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely levonorgestrel 30 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel 37.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel 37.5 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing levonorgestrel 0.75 mg/1 each oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing levonorgestrel 0.75 mg/1 each oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel 1.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel 1.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	1
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing only ethinyl estradiol 0.05 mg and levonorgestrel 0.25 mg/1 each oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	2
Product containing only ethinyl estradiol 0.05 mg and levonorgestrel 0.25 mg/1 each oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	1
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	2
Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	2
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	2
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	1
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel 37.5 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel 1.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely levonorgestrel 30 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levonorgestrel	Inferred relationship	Some	1
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levonorgestrel	Inferred relationship	Some	2
Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levonorgestrel	Inferred relationship	Some	1
Ethinylestradiol- and levonorgestrel-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	2
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levonorgestrel	Inferred relationship	Some	1
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Levonorgestrel	Inferred relationship	Some	1
Product containing levonorgestrel in subcutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Product containing levonorgestrel in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing estradiol and levonorgestrel in transdermal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel-containing product in intrauterine dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing only estradiol and levonorgestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Ethinylestradiol and levonorgestrel only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	2
Product containing only levonorgestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Estradiol and levonorgestrel only product in transdermal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing only levonorgestrel in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing only ethinylestradiol and levonorgestrel in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	2
Product containing only levonorgestrel in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing only levonorgestrel in intrauterine dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing only levonorgestrel in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel 75 mg prolonged-release subcutaneous implant	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel 75 mg prolonged-release subcutaneous implant	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levonorgestrel	Inferred relationship	Some	1
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	1
Product containing only levonorgestrel in subcutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levonorgestrel	Inferred relationship	Some	1
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Levonorgestrel	Inferred relationship	Some	1
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Levonorgestrel	Inferred relationship	Some	1
Levonorgestrel-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levonorgestrel	Inferred relationship	Some	1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
12082010	Levonorgestrel	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
730029013	Levonorgestrel (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
58331000195116	levonorgestrel	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
820681000172116	lévonorgestrel	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
73421000195119	Levonorgestrel	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module